Skip to content

PTSD: all studies

Page 141 of 210: studies 1,401 to 1,410 of 2,096, newest first. Back to the PTSD overview

Research

Could the medicalization of psychedelics lead to the next generation of antidepressants?

The Biochemist March 28, 2024 Peter J. Duggan, S. Walker 1 citation

A major part of the counterculture that emerged in western societies in the 1960s centred around the use of mind-altering psychedelic drugs such as lysergic acid diethylamide (LSD). Humans had, however, been consuming hallucinogenic substances since prehistoric times and often incorporated them into their religious rituals. Concerns over the effects of potent psychedelics like LSD led to them...

Trauma Under Psychedelics: How Psychoactive Substances Impact Trauma Processing

bioRxiv Preprint Server March 28, 2024 Ophir Netzer, Noa Magal, Yonatan Stern et al. 7 citations preprint

Traumatic events play a causal role in the etiology of stress-related psychopathologies such as depression and posttraumatic stress disorder (PTSD). Recent research highlighted the therapeutic potential of psychoactive substances in alleviating trauma symptoms among chronic stress-related patients. This study is the first to investigate the impact of psychoactive substances consumed during...

Psychedelic-assisted therapy for people with gambling disorder?

Journal of Behavioral Addictions March 26, 2024 Pedro Romero, Andrea Czakó, Wim van den Brink et al. 7 citations

Abstract Gambling disorder is a severe mental health and behavioural problem with harmful consequences, including financial, relationship and mental health problems. The present paper initiates discussion on the use of psychedelics combined with psychotherapeutic support as a potential treatment option for people living with a gambling disorder. Recent studies have shown promising results using...

Psychedelic Drugs: A Mind-expanding Hallucinogens

Indian Journal of Behavioural Sciences March 22, 2024 Shreyasee Das, Rahul Shil

Psychedelics are mainly from the class of psychoactive substances whose action is to produce changes in the perception, mood, cognitive behavior, and processes of a person. This psychedelic drug creates an alteration in a person’s thinking, sense of time, and emotions. Hallucinations can be a main cause for people who take psychedelics. Mainly, these psychedelic drugs have been used since...

An examination of internal family systems interventions for trauma with implications for ethical psychedelic-assisted treatment

Journal of Psychedelic Studies March 5, 2024 Mitch Earleywine, Alyssa B. Oliva, Joseph A. de Leo et al. 6 citations

Though several treatments effectively address the pervasive impact of trauma, they do not achieve complete symptom resolution for all clients, inspiring the search for alternatives. Internal Family Systems (IFS) therapy has grown popular, especially in informal psychedelic-assisted treatments (PAT). Compared to stereotypes of empirically validated, exposure-based treatments, IFS has novel...

Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine

American Journal of Therapeutics March 1, 2024 Kirsten Cherian, Kenneth Shinozuka, Burton J. Tabaac et al. 9 citations

BACKGROUND: Ibogaine is a plant-derived alkaloid that has been used for thousands of years in rites of passage and spiritual ceremonies in West-Central Africa. In the West, it has primarily been used and studied for its anti-addictive properties and more recently for other neuropsychiatric indications, including post-traumatic stress disorder, depression, anxiety, and traumatic brain injury....

MDMA enhances positive affective responses to social feedback.

Journal of Psychopharmacology March 1, 2024 Anya K. Bershad, David T Hsu, Harriet de Wit 9 citations

The prosocial compound ± 3,4-methylenedioxymethamphetamine (MDMA) is an amphetamine derivative that has shown promise as an adjunct to psychotherapy in the treatment of post-traumatic stress disorder. MDMA increases positive responses to social images, and it has been suggested that the ability of MDMA to positively bias social perception may underlie its therapeutic efficacy as a psychotherapy...

DOI: 10.1177/02698811231224153 (opens in new tab) Full text (opens in new tab) MDMA Social acceptance Social feedback Social rejection

Recreational MDMA doses do not elicit hepatotoxicity in HepG2 spheroids under normo- and hyperthermia.

Toxicology March 1, 2024 Arthur L. De Oliveira, Raul G Miranda, Daniel J Dorta 1 citation

MDMA (3,4-methylenedioxymethamphetamine), an entactogen with empathogenic and prosocial effects, is widely used in music festivals and other festive settings. High MDMA doses have been associated with drug-induced liver injury and cases of hyperthermia. Although the latter condition is thought to increase MDMA hepatotoxicity, this correlation remains poorly explored for recreational MDMA doses....

DOI: 10.1016/j.tox.2024.153761 (opens in new tab) Full text (opens in new tab) Tridimensional cell culture Drug research MDMA/Ecstasy/Molly/E Liver toxicity/hepatotoxicity/citotoxicity

The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness

Psychoactives February 26, 2024 Frankie A. Colosimo, Philip Borsellino, Reese I. Krider et al. 8 citations

The human brain is an extraordinarily complex organ responsible for all aspects of cognition and control. Billions of neurons form connections with thousands of other neurons, resulting in trillions of synapses that create a vast and intricate network. This network is subjected to continuous remodeling that adapts to environmental and developmental changes. The resulting neuroplasticity is...

Cannabis and Anxiety: A Critical Review

Medical Cannabis and Cannabinoids February 23, 2024 Alexander Beletsky, Cherry Liu, Bryson Lochte et al.

Abstract Introduction: Cannabis has been reported to have both anxiogenic and anxiolytic effects. Habitual cannabis use has been associated with anxiety disorders (AD). The causal pathways and mechanisms underlying the association between cannabis use (CU)/cannabis use disorder (CUD) and anxiety remain unclear. We examined the literature via a systematic review to investigate the link between...